Global Biomarkers Market By Type (Safety Biomarkers, Efficacy Biomarkers, Predictive Biomarkers, Surrogate Biomarkers, Pharmacodynamic Biomarkers, Prognostics Biomarkers, Validation Biomarkers) By Product (Consumable, Services, Software) By Application (Diagnostics, Drug Discovery & Development, Personalized Medicine, Disease Risk Assessment, Others) By Disease (Cancer,Cardiovascular Diseases, Neurological Diseases, Immunological Diseases, Others) Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Sep 2024
- Report ID: 129675
- Number of Pages: 249
- Format:
-
keyboard_arrow_up
-
-
- F. Hoffmann-La Roche AG
- Epigenomics AG
- Abbott Laboratories
- Thermo Fisher Scientific Company Profile
- General Electric
- Eurofins Scientific
- Johnson & Johnson Services, Inc.
- QIAGEN NV Company Profile
- Bio-Rad Laboratories, Inc. Company Profile
- Siemens Healthineers AG
- Merck KGaA Company Profile
- PerkinElmer Inc.
- Agilent Technologies, Inc.
- settingsSettings
Our Clients
- 129675
- Sep 2024
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
|
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |
